PATENT CLAIM ANALYSIS

Application Number: 16007417
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "235800"]

Abstract:
Aminothiazole compounds of Formula (I) shown below and pharmaceutical compositions containing one of such compounds: Also disclosed are methods of inhibiting a tyrosine kinase and treating cancer associated with a tyrosine kinase with one of the aminothiazole compounds.

Claim (Index 10):
The compound or salt of  claim 3 , wherein R 3  is 5- or 6-membered heteroaryl substituted with one or more (CH 2 ) n Z moieties independently, in which n is 0 or 1 and Z is H, halo, CN, OH, CF 3 , C 1-6  alkyl, or C 1-6  alkoxyl; or is 5- or 6-membered heteroaryl fused with a phenyl ring substituted with one or more substituents independently selected from the group consisting of H, halo, CN, OH, CF 3 , C 1-6  alkyl, and C 1-6  alkoxyl.

Metadata:
- Claim Count in Document: 39.0
- Percentile: 94.0
- Lexical Diversity: 1.35484
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15419183', '15257926', '15861688', '14670421', '14670425']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7994061081267987
- 35 USC 102 Novelty (BERT): 0.5383274473840896
- Combined Prediction Score: 0.7732982420525277
- Mean Citation Score: 323.369304
- Max Citation Score: 366.57004
- Similarity Product: 293.29842396727327

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test